Hepatitis B mediated glomerulonephritis in children

Area of Science:

• Pediatric Nephrology
• Hepatology
• Virology

Background:

• Hepatitis B virus (HBV) infection is a significant cause of glomerulonephritis (GN) in children.
• Understanding the clinical course and outcomes of HBV-mediated GN is crucial for effective management.

Purpose of the Study:

• To analyze the clinical characteristics, histological findings, and outcomes of HBV-mediated glomerulonephritis in a pediatric cohort.
• To evaluate the efficacy of immunosuppressive therapy and indomethacin in managing this condition.

Main Methods:

• Retrospective observational study of 49 children diagnosed with HBV-mediated GN over 11 years.
• Analysis of demographic data, clinical presentation, kidney biopsy findings (membranous, mesangiocapillary, mesangial proliferative GN), and treatment outcomes.
• Assessment of disease self-limiting nature and persistence of liver disease post-GN resolution.

Main Results:

• Boys (38:11 ratio) and young infants (1-5 years) were predominantly affected.
• Membranous GN was the most common histological type (77%), followed by mesangiocapillary GN (18%) and mesangial proliferative GN (5%).
• The disease was self-limiting in most cases, with no significant modification of course or outcome by immunosuppressive drugs or indomethacin. Liver disease often persisted after GN resolution.

Conclusions:

• HBV-mediated glomerulonephritis in children typically follows a self-limiting course, predominantly presenting as membranous nephropathy.
• Standard treatments do not appear to alter the renal disease's outcome, highlighting the importance of supportive care.
• Persistent liver disease post-glomerulonephritis resolution warrants continued monitoring in affected children.